Form 4: Avanos Medical SVP, General Counsel Mojirade James Receives 16,300 Restricted Share Units

Mojirade James, SVP and General Counsel of Avanos Medical, Inc., was granted 16,300 time-based restricted share units (TRSUs) on April 22, 2025, which will vest on April 22, 2026.

Summary

• On April 22, 2025, Mojirade James, the SVP and General Counsel of Avanos Medical, Inc. (AVNS), received 16,300 time-based restricted share units (TRSUs).
• These TRSUs were awarded under the Issuer's 2021 Long Term Incentive Plan, as amended.
• The awarded TRSUs will vest on April 22, 2026.
• Each TRSU represents the economic equivalent of one share of Avanos Medical's common stock.
• Following this transaction, Mojirade James beneficially owns 104,518 shares of Avanos Medical common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the executive's continued contribution to the company. There are no explicit negative indicators.

Positives

• The grant of restricted share units aligns the executive's interests with those of the shareholders.
• The vesting period of one year encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of the restricted share units on April 22, 2026, suggests a continued employment relationship.

Industry Context

Granting restricted stock units is a common practice in corporate governance to incentivize executives and align their interests with those of the shareholders. The specific terms of the grant, such as the vesting schedule, are typical for executive compensation packages.

Comparison to Industry Standards

• The use of time-based restricted share units (TRSUs) is a common compensation practice among publicly traded companies to incentivize executives.
• Vesting schedules, such as the one-year vesting period for these TRSUs, are typical in executive compensation packages to encourage long-term commitment.
• Companies like Medtronic, Johnson & Johnson, and Baxter International also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view the grant of restricted share units positively, as it aligns executive interests with long-term company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Avanos Medical, Mojirade James, Restricted Share Units, TRSUs, Beneficial Ownership, Form 4, Incentive Plan, Vesting